Oxytrol for Women FDA Approval History
FDA Approved: Yes (First approved January 25, 2013)
Brand name: Oxytrol for Women
Generic name: oxybutynin
Dosage form: Transdermal System
Company: Allergan plc
Treatment for: Overactive Bladder
Oxytrol for Women (oxybutynin) is a muscarinic receptor antagonist transdermal patch available over-the-counter for the treatment of overactive bladder in women.
Development timeline for Oxytrol for Women
| Date | Article |
|---|---|
| Jan 25, 2013 | Approval FDA Approves Over-the-Counter Oxytrol for Women to treat Overactive Bladder |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.